Ajou University
Also known as: Ajoun university hospital | Ajou University | Ajou University Hospital, Korea | Ajou University Hospital of Korea | Ajou University Hospital, Psychiatry | Ajou University Hospital, Suwon, Gyeongki-do, Korea | Ajou University Hospital, Suwon, Gyeongki-do, Korea, | Ajou University Hospital, Suwon, Gyeongki-do, South Korea, 443-721 | Ajou university hospotal | Ajou University Medical Center | Ajou University Medical Center, Suwon, Kyunggi-do, Korea, Republic of | Ajou University Medical Centre | Ajou University School of Medicine | Ajou Universiy School of Medicine | Ajou unversity medical center | Aju University Hospital | AJU University Hospital | Cardiovascular Center, Ajou University Hospital | Department of medicine, Ajou University School of Medicine | Department of surgery, Ajou University School of Medicine | Jin Soon Hwang
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Dec 31, 2024
Timeline
1970s
- Jan 1, 1973
Ajou University— Founded
Drugs by trial phase (114 distinct, 131 trials)
Phase 4 (55 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Other trials (12 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Adenocarcinoma
- Alzheimer Disease
- Angina, Stable
- Angina, Unstable
- Anovulation
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Asthma
- Atrial Fibrillation
- Birth Weight
- Bradycardia
- Brain Ischemia
- Brain Neoplasms
- Bronchopulmonary Dysplasia
- Cerebral Infarction
- Coronary Artery Disease
- Coronary Disease
- Depression
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Diabetic Retinopathy
- Disease
- Dwarfism
- Dyslipidemias
- Emergence Delirium
- Endometriosis
- Essential Hypertension
- Fatigue
- Fatigue Syndrome, Chronic
- Foot Ulcer
- Gastritis
- Gastroesophageal Reflux
- Glioblastoma
- Gliosarcoma
- Glomerulonephritis
- Gonadal Dysgenesis
- Heart Diseases
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hernia, Inguinal
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertension
- IgG Deficiency
- Infertility
- Intermittent Claudication
- Ischemia
- Keratosis
- Keratosis, Actinic
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Liver Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Moyamoya Disease
- Myocardial Ischemia
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Neovascularization, Pathologic
- Osteoarthritis
- Osteoarthritis, Knee
- Osteoporosis
- Peripheral Arterial Disease
- Prediabetic State
- Premature Birth
- Proteinuria
- Psychomotor Agitation
- Puberty, Precocious
- Pulmonary Disease, Chronic Obstructive
- Renal Insufficiency, Chronic
- Retinal Diseases
- Small Cell Lung Carcinoma
- Spondylitis
- Spondylitis, Ankylosing
- Stomach Ulcer
- Stroke
- Syndrome
- Torticollis
- Turner Syndrome
- Ulcer
- Vitamin D Deficiency
- Wounds and Injuries
Recent trials (50)
- NCT06714513OfficialPhase 1Dec 31, 2024
- NCT06622603CollaboratorPhase 4Oct 15, 2024
- NCT06123624Lead sponsorN/ANov 27, 2023
- NCT06123624Reponsible party - principal investigatorN/ANov 27, 2023
- NCT05751603Lead sponsorN/AOct 3, 2023
- NCT05751603Reponsible party - principal investigatorN/AOct 3, 2023
- NCT06015711Overall official - principal investigatorN/AAug 30, 2023
- NCT06015711Reponsible party - principal investigatorN/AAug 30, 2023
- NCT06015711Lead sponsorN/AAug 30, 2023
- NCT05960708Study chairPhase 1Aug 23, 2023
- NCT06025409Overall official - principal investigatorPhase 3Aug 1, 2023
- NCT05564221Study chairPhase 1Nov 1, 2022
- NCT05478382Reponsible party - principal investigatorPhase 4Oct 31, 2022
- NCT05478382Overall official - principal investigatorPhase 4Oct 31, 2022
- NCT05478382Lead sponsorPhase 4Oct 31, 2022
Details
- Founded
- Suwon-si, KR Jan 1, 1973
- Last known activity
- Dec 31, 2024